These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21047982)

  • 21. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein expression predicts disease severity in chronic hepatitis C patients.
    Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Hsieh MH; Dai CY; Hsieh MY; Lin ZY; Chen SC; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Aug; 33(8):394-399. PubMed ID: 28811008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C.
    Xu H; Kong W; Liu L; Chi X; Wang X; Wu R; Gao X; Wang H; Qu L; Qi Y; Pan Y; Niu J
    BMC Gastroenterol; 2017 May; 17(1):62. PubMed ID: 28486931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I; El Rahman AT; El-Alim MA; Zaki SS
    Egypt J Immunol; 2003; 10(1):27-35. PubMed ID: 15719620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics.
    Narimatsu H
    Expert Rev Proteomics; 2015; 12(6):683-93. PubMed ID: 26394846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of chronic hepatitis C patients related to baseline liver fibrosis stage: a hospital-based linkage study.
    Huang Y; de Boer WB; Adams LA; MacQuillan G; Bulsara MK; Jeffrey GP
    Intern Med J; 2015 Jan; 45(1):48-54. PubMed ID: 25371273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis.
    Ocho M; Togayachi A; Iio E; Kaji H; Kuno A; Sogabe M; Korenaga M; Gotoh M; Tanaka Y; Ikehara Y; Mizokami M; Narimatsu H
    J Proteome Res; 2014 Mar; 13(3):1428-37. PubMed ID: 24422531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.
    Tokgöz Ö; Unal I; Turgut GG; Yildiz S
    Acta Clin Belg; 2014 Dec; 69(6):426-32. PubMed ID: 25103596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fabrication of highly stable glyco-gold nanoparticles and development of a glyco-gold nanoparticle-based oriented immobilized antibody microarray for lectin (GOAL) assay.
    Huang LD; Adak AK; Yu CC; Hsiao WC; Lin HJ; Chen ML; Lin CC
    Chemistry; 2015 Mar; 21(10):3956-67. PubMed ID: 25571858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C.
    Ichikawa S; Motosugi U; Ichikawa T; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
    Magn Reson Med Sci; 2012; 11(4):291-7. PubMed ID: 23269016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS).
    Teshale E; Lu M; Rupp LB; Holmberg SD; Moorman AC; Spradling P; Vijayadeva V; Boscarino JA; Schmidt MA; Gordon SC;
    J Viral Hepat; 2014 Dec; 21(12):917-20. PubMed ID: 25131445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    Tawara S; Tatsumi T; Iio S; Kobayashi I; Shigekawa M; Hikita H; Sakamori R; Hiramatsu N; Miyoshi E; Takehara T
    PLoS One; 2016; 11(3):e0151828. PubMed ID: 27002630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.
    Boyd A; Bottero J; Miailhes P; Lascoux-Combe C; Rougier H; Girard PM; Serfaty L; Lacombe K
    J Int AIDS Soc; 2017 Feb; 20(1):21426. PubMed ID: 28362068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B-mode ultrasound with algorithm based on statistical analysis of signals: evaluation of liver fibrosis in patients with chronic hepatitis C.
    Toyoda H; Kumada T; Kamiyama N; Shiraki K; Takase K; Yamaguchi T; Hachiya H
    AJR Am J Roentgenol; 2009 Oct; 193(4):1037-43. PubMed ID: 19770327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced expression of alpha1-acid glycoprotein and fucosylation in hepatitis B patients provides an insight into pathogenesis.
    Mondal G; Chatterjee U; Das HR; Chatterjee BP
    Glycoconj J; 2009 Dec; 26(9):1225-34. PubMed ID: 19459043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling.
    Meany DL; Hackler L; Zhang H; Chan DW
    J Proteome Res; 2011 Mar; 10(3):1425-31. PubMed ID: 21133419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.